This could explain the observations that the SWI/SNF complex can decrease MYC's binding to some of its target genes in lung cancer cell lines; and that when INI1 is introduced into INI1‐deficient rhabdoid tumor cells, MYC binding is reduced at some of its target genes 22. The gene discussed is SMARCB1; the disease is lung cancer.